Skip to main content

Table 2 Univariate and multivariate analysis of recurrence survival for adenocarcinoma

From: Effect of initial recurrence site on the prognosis of different tissue types of non-small cell lung cancer: a retrospective cohort study

Post-recurrence survival variable

Univariate

HR1 (95% CI1)

p-value5

Multivariate

HR1 (95% CI1)

p-value5

Sex

 Male

1.0 (reference)

   

 Female

0.88 (0.66, 1.16)

0.363

  

Age group

  < 60

1.0 (reference)

   

  ≥ 60

0.98 (0.73, 1.30)

0.884

  

BMI1 group

  < 24

1.0 (reference)

   

  ≥ 24

0.74 (0.55, 1.00)

0.052

  

Surgical mode

 Lobectomy

1.0 (reference)

   

 Segmentectomy

0.29 (0.04, 2.05)

0.213

  

 Wedge resection

1.44 (0.96, 2.16)

0.081

  

 Total pneumonectomy

1.29 (0.32, 5.20)

0.722

  

Tumor differentiation

 Unknown

1.0 (reference)

   

 Medium differentiation

0.85 (0.52, 1.39)

0.522

  

 Low differentiation

1.19 (0.78, 1.80)

0.420

  

 Undifferentiation

0.50 (0.07, 3.57)

0.488

  

 Medium–low differentiation

1.88 (0.60, 5.89)

0.281

  

Vascular cancer thrombus

 No

1.0 (reference)

 

1.0 (reference)

 

 Yes

1.93 (1.08, 3.47)

0.027

2.00 (1.11, 3.61)

0.021

Bronchial stump

 No

1.0 (reference)

   

 Yes

1.62 (0.98, 2.67)

0.058

  

Pleural invasion

 No

1.0 (reference)

   

 Yes

0.85 (0.56, 1.28)

0.427

  

AJCC1 8th ed. stage

 AICC <  = II stage

1.0 (reference)

 

1.0 (reference)

 

 AICC > II stage

1.78 (1.34, 2.37)

 < 0.001

1.70 (1.27, 2.27)

 < 0.001

Adjuvant chemotherapy

 No

1.0 (reference)

   

 Yes

0.87 (0.61, 1.22)

0.415

  

Adjuvant radiation therapy

 No

1.0 (reference)

   

 Yes

0.89 (0.65, 1.22)

0.474

  

Postoperative targeted therapy

 No

1.0 (reference)

   

 Yes

0.97 (0.61, 1.54)

0.891

  

Two sites

 No

1.0 (reference)

   

 Yes

0.96 (0.63, 1.45)

0.839

  

Three or more recurrence sites

 No

1.0 (reference)

 

1.0 (reference)

 

 Yes

1.80 (1.22, 2.66)

0.003

1.60 (1.07, 2.39)

0.022

Lung recurrence

 No

1.0 (reference)

 

1.0 (reference)

 

 Yes

0.56 (0.37, 0.84)

0.005

0.62 (0.41, 0.95)

0.027

Brain recurrence

 No

1.0 (reference)

   

 Yes

0.96 (0.68, 1.35)

0.804

  

Bone recurrence

 No

1.0 (reference)

   

 Yes

1.44 (0.99, 2.09)

0.058

  

Abdominal organs2 recurrence

 No

1.0 (reference)

   

 Yes

1.05 (0.49, 2.24)

0.896

  

Pleural recurrence

 No

1.0 (reference)

 

1.0 (reference)

 

 Yes

1.99 (1.05, 3.77)

0.034

2.18 (1.14, 4.17)

0.018

Lymph node4 recurrence

 No

1.0 (reference)

   

 Yes

0.64 (0.38, 1.08)

0.094

  

Multisite3 recurrence

 No

1.0 (reference)

   

 Yes

1.35 (0.99, 1.83)

0.057

  
  1. 1Abbreviations: BMI, body mass index; AJCC, American Joint Committee on Cancer; CI, confidence interval; HR, hazard ratio. 2Abdominal organs (liver + adrenal). 3Multisite (two or more organs). 4Lymph node (hilar, supraclavicular, and thoracic lymph nodes). 5P-value, using Pearson’s chi-squared test. Wilcoxon rank-sum test. Fisher’s exact test